L’action GSK chute de 9 % à la suite de l’approbation par un tribunal de la poursuite de 70 000 actions en justice concernant le Zantac
Read the full article here:
Read the full article here:
Read the full article here:
Read the full article here:
Read the full article here:
Read the full article here:
Read the full article here: